Pell Bio-Med Technology Co., Ltd. (TPE:6949)
Taiwan
· Delayed Price · Currency is TWD 560.00
-4.00 (-0.71%)
Mar 9, 2026, 1:30 PM CST
Pell Bio-Med Technology Market Cap
Pell Bio-Med Technology has a market cap or net worth of 36.42 billion as of March 9, 2026. Its market cap has increased by 517.72% in one year.
Market Cap
36.42B
Enterprise Value
36.22B
Revenue
29.99M
Ranking
n/a
PE Ratio
n/a
Stock Price
560.00
Market Cap Chart
Since March 8, 2024, Pell Bio-Med Technology's market cap has increased from 5.56B to 36.42B, an increase of 555.49%. That is a compound annual growth rate of 156.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 36.42B | 81.54% |
| Dec 31, 2025 | 20.06B | 324.81% |
| Dec 31, 2024 | 4.72B | -15.00% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lin BioScience | 33.05B |
| Lumosa Therapeutics | 26.36B |
| Oneness Biotech | 26.27B |
| Polaris Group | 23.58B |
| Sunmax Biotechnology | 21.21B |
| EirGenix | 18.10B |
| TaiMed Biologics | 14.62B |
| AP Biosciences | 14.46B |